MHRAsafety guidance72% confidence
Guidance: Clinical trials for medicines: roles and responsibilities
Source: MHRA
Why This Matters
Why this matters: illustrates how regulators handled a comparable safety guidance decision relevant to Gilead.
Regulatory Analysis
Which professions can act as an investigator, training and experience expectations, provision of medical support and delegation of activities.
Supporting Context
- Therapeutic area
- Infectious Disease · HIV
- Sub-indication
- General
Related signal: Islatravir and Lenacapavir Show Sustained Virologic Suppression in Phase 3 HIV Trials